Eli Lilly & Daiichi’s Efient Gets Clearance in Europe for Heart
Submitted by Amit Pathania on Tue, 02/24/2009 - 08:03
Eli Lilly & Co and Japan's Daiichi Sankyo Co won European approval for their blood-thinning drug Efient, also known as prasugrel to treat heart patients with acute coronary syndrome who get artery-clearing angioplasty procedures.
Latest News
|
|
|
|
|
|
|
|
|
|
|
|
